vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - cjepiva - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. korištenje ovog cjepiva mora se provoditi u skladu sa službenim preporukama.
vyepti
h. lundbeck a/s - eptinezumab - migrena poremećaja - analgetici - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
vitamin c 500 mg/5 ml rastvor za injekciju
galenika d.o.o. - askorbinska kiselina - rastvor za injekciju - 500 mg/5 ml - 5 ml rastvora za injekciju sadrži: 500 mg askorbinska kiselina
vydura
pfizer europe ma eeig - rimegepant - migrena poremećaja - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
vitamin c galenika 500 mg/5 ml rastvor za injekciju
galenika d.o.o. - askorbinska kiselina - rastvor za injekciju - 500 mg/5 ml - 5 ml rastvora za injekciju sadrži: 500 mg askorbinske kiseline
polinol 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta tableta
alpen pharma d.o.o. - cardiospermum, galfimia Глаука diehl. d3, Д4 люффы operculata Трит. - tableta - 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta - jedna tableta sadrži: 25 mg luffa operculata trit. d4 25 mg galphimia glauca trit. d3 25 mg cardiospermum trit. d3
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
osan 40 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - telmisartanum - tableta - 40 mg - urbroj: jedna tableta sadrži 40 mg telmisartana
osan 80 mg tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - telmisartanum - tableta - 80 mg - urbroj: jedna tableta sadrži 80 mg telmisartana
tolura 20 mg/1 tableta tableta
krka farma d.o.o. sarajevo - telmisartan - tableta - 20 mg/1 tableta - 1 tableta sadrži: 20 mg telmisartana